TREATMENT OF TRIPLE RECEPTOR NEGATIVE BREAST CANCER

摘要

The present invention relates to the use of a liposomal preparation for the manufacture of a pharmaceutical composition and the use of such a composition for the treatment of "triple receptor negative" breast cancer.